Bill & Melinda Gates Foundation Pledges up to $90M to Fund Inventprise’s 25-Strain Pediatric Pneumococcal Vaccine Trials
Seattle-area biotech Inventprise will use up to $90 million from the Bill & Melinda Gates Foundation to advance a 25-strain pediatric pneumococcal vaccine into phase 1 and 2 human trials, contingent on meeting development and manufacturing milestones.
No comments yet.